Ontology highlight
ABSTRACT: Importance
There is a need for validated clinical end points that are reliably able to quantify potential therapeutic effects of future treatments targeting age-related macular degeneration (AMD) before the onset of serious visual impairment.Objective
To assess the reliability and discriminatory power of 5 simple chart-based visual function (VF) tests as potential measures for clinical trial end points with regulatory and patient-access intention in intermediate AMD (iAMD).Design, setting, and participants
This international noninterventional study took place at 18 tertiary ophthalmology departments across Europe. Participants were recruited between April 2018 and March 2020 and were identified during routine clinical review. Participants with no AMD and early AMD w
SUBMITTER: Dunbar HMP
PROVIDER: S-EPMC9227684 | biostudies-literature | 2022 Aug
REPOSITORIES: biostudies-literature